73 related articles for article (PubMed ID: 11107747)
1. [Interleukin-18 and new drugs. Protective effect against tumor growth and infections].
Wollheim FA
Lakartidningen; 2000 Oct; 97(41):4604. PubMed ID: 11107747
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-18: biological properties and clinical implications.
Lebel-Binay S; Berger A; Zinzindohoué F; Cugnenc P; Thiounn N; Fridman WH; Pagès F
Eur Cytokine Netw; 2000 Mar; 11(1):15-26. PubMed ID: 10705295
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens.
Biet F; Locht C; Kremer L
J Mol Med (Berl); 2002 Mar; 80(3):147-62. PubMed ID: 11894141
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 and the treatment of rheumatoid arthritis.
Dinarello CA
Rheum Dis Clin North Am; 2004 May; 30(2):417-34, ix. PubMed ID: 15172050
[TBL] [Abstract][Full Text] [Related]
5. [Interleukin-18].
Fol M; Gościcka T
Postepy Hig Med Dosw; 2003; 57(6):685-99. PubMed ID: 15002164
[TBL] [Abstract][Full Text] [Related]
6. The structure and binding mode of interleukin-18.
Kato Z; Jee J; Shikano H; Mishima M; Ohki I; Ohnishi H; Li A; Hashimoto K; Matsukuma E; Omoya K; Yamamoto Y; Yoneda T; Hara T; Kondo N; Shirakawa M
Nat Struct Biol; 2003 Nov; 10(11):966-71. PubMed ID: 14528293
[TBL] [Abstract][Full Text] [Related]
7. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
Han SB; Park SH; Jeon YJ; Kim YK; Kim HM; Yang KH
J Pharmacol Exp Ther; 2001 Nov; 299(2):415-25. PubMed ID: 11602650
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-18 and the pathogenesis of inflammatory diseases.
Dinarello CA
Semin Nephrol; 2007 Jan; 27(1):98-114. PubMed ID: 17336692
[TBL] [Abstract][Full Text] [Related]
9. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement.
Okazawa A; Kanai T; Watanabe M; Yamazaki M; Inoue N; Ikeda M; Kurimoto M; Ishii H; Hibi T
Am J Gastroenterol; 2002 Dec; 97(12):3108-17. PubMed ID: 12492197
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways.
Cho ML; Jung YO; Moon YM; Min SY; Yoon CH; Lee SH; Park SH; Cho CS; Jue DM; Kim HY
Immunol Lett; 2006 Mar; 103(2):159-66. PubMed ID: 16368150
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
[TBL] [Abstract][Full Text] [Related]
12. Cytokine recognition by human interleukin 5 receptor.
Ishino T; Robertson N; Chaiken I
Vitam Horm; 2005; 71():321-44. PubMed ID: 16112273
[TBL] [Abstract][Full Text] [Related]
13. IL-33: a promising therapeutic target for rheumatoid arthritis?
Yuan FL; Li X; Lu WG; Li CW; Xu RS; Dong J
Expert Opin Ther Targets; 2011 May; 15(5):529-34. PubMed ID: 21446881
[TBL] [Abstract][Full Text] [Related]
14. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
[TBL] [Abstract][Full Text] [Related]
15. Effects of pro- and anti-inflammatory cytokines and nitric oxide donors on hyaluronic acid synthesis by synovial cells from patients with rheumatoid arthritis.
Chenevier-Gobeaux C; Morin-Robinet S; Lemarechal H; Poiraudeau S; Ekindjian JC; Borderie D
Clin Sci (Lond); 2004 Sep; 107(3):291-6. PubMed ID: 15149282
[TBL] [Abstract][Full Text] [Related]
16. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
[TBL] [Abstract][Full Text] [Related]
17. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.
Matsuoka K; Inoue N; Sato T; Okamoto S; Hisamatsu T; Kishi Y; Sakuraba A; Hitotsumatsu O; Ogata H; Koganei K; Fukushima T; Kanai T; Watanabe M; Ishii H; Hibi T
Gut; 2004 Sep; 53(9):1303-8. PubMed ID: 15306590
[TBL] [Abstract][Full Text] [Related]
18. An early imbalance of interleukin 12 influences the adjuvant effect of mannoproteins of Cryptococcus neoformans.
Pietrella D; Lupo P; Bistoni F; Vecchiarelli A
Cell Microbiol; 2004 Sep; 6(9):883-91. PubMed ID: 15272868
[TBL] [Abstract][Full Text] [Related]
19. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
Radstake TR; Roelofs MF; Jenniskens YM; Oppers-Walgreen B; van Riel PL; Barrera P; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Dec; 50(12):3856-65. PubMed ID: 15593217
[TBL] [Abstract][Full Text] [Related]
20. IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants.
de Paus RA; van de Wetering D; van Dissel JT; van de Vosse E
Mol Immunol; 2008 Sep; 45(15):3889-95. PubMed ID: 18675459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
